Today (November 19th, 2013) the U.S. Food and Drug Administration allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as "next generation sequencing" (NGS). These instruments, reagents, and test systems allow labs to sequence a patient's DNA (deoxyribonucleic acid).The new technology also gives physicians the ability to take a broader look at their patients' genetic makeup and can help in diagnosing disease or identifying the cause of symptoms."NGS is changing the way we look at genomics," said Alberto Gutierrez, Ph.D.
More...
More...